Heal Capital

Heal Capital is a Berlin-based venture investment firm established in 2019, specializing in the HealthTech sector. With total investments exceeding EUR 200 million, it focuses on supporting mission-driven founders by providing capital and expertise tailored to the unique challenges of healthcare technology. The firm primarily targets early-stage companies, ranging from pre-seed to Series A funding rounds, to facilitate their market access within the healthcare system. By leveraging its deep understanding of both healthcare and technology, Heal Capital aims to drive innovation and growth in the digital health landscape across Europe.

Hana Besbes

Venture Partner

Ivana Jelic

Venture Partner

Marta Mrozowicz

Investment Manager

Eckhardt Weber

Co-Founder and Managing Partner

Christian Weiss

General Partner

Peter Wibbe

Founding Partner

29 past transactions

CGC Genomics

Pre Seed Round in 2025
At CGC Genomics (CGC) we are deeply committed to advancing the field of cancer care through complex, precision genomics analysis and report interpretation. We distill complex genomic data into concise, actionable insights for healthcare providers, reducing interpretation times and facilitating timely, personalized treatment recommendations for 10 million patients with metastatic cancer.​ Our years of experience interpreting and supporting thousands of the most complicated cancer genomics cases around the world enables CGC to offer healthcare providers timely, expert cancer genomics analysis and consultation support, delivering world-class expertise wherever and whenever needed.

Hema.to

Seed Round in 2025
Hema.to is a developer of clinical support software that specializes in automated, AI-powered detection suggestions for blood cancer, utilizing flow cytometry data. The company's platform offers comprehensive decision support, taking users from raw flow files to complete diagnostic reports. By focusing on the needs of hematology laboratories, Hema.to aims to enhance operational efficiency while ensuring high-quality results. Its tools are specifically designed to meet the unique requirements of clinical flow, empowering labs to provide better patient care through advanced technology.

Apheris

Series A in 2025
Apheris specializes in network security for deep learning and privacy, providing a platform that enables secure data sharing and collaborative analysis of distributed datasets. By utilizing artificial intelligence, decentralized computing, federated learning, and cryptographic protocols, Apheris ensures that sensitive information remains protected in low or zero trust environments. This approach allows organizations to unlock the full potential of their data while adhering to stringent privacy and data protection regulations. The company’s solutions fundamentally change how organizations collaborate securely and extract value from their data, promoting a safer and more efficient analytical process.

Heim Health

Seed Round in 2024
Heim Health is a healthcare firm using technology to deliver scalable, community-based solutions.

Paloma Health

Pre Seed Round in 2024
A technology-enabled provider of children's mental health services, starting with autism assessments.

Parto

Pre Seed Round in 2024
Parto services include business accounts, accounts with fiduciary custody, and payment cards for staff members and those receiving care. Using our proprietary software, which allows for automated billing of business expenses and digital custody fund administration.

Gleamer

Series B in 2023
Gleamer develops artificial intelligence solutions tailored for radiology, focusing on enhancing diagnostic accuracy and efficiency in medical imaging. The company's AI Companions integrate seamlessly into the existing workflow of radiologists, providing automated second readings that assist in detecting and highlighting bone abnormalities on X-ray images. This technology enables the early identification of lesions and prioritization of patient care, helping to ensure that diagnoses are made promptly and accurately. Currently, Gleamer's solutions are utilized in over 300 institutions across 13 countries, reflecting the widespread adoption of its advanced diagnostic tools in the healthcare sector.

Hema.to

Seed Round in 2023
Hema.to is a developer of clinical support software that specializes in automated, AI-powered detection suggestions for blood cancer, utilizing flow cytometry data. The company's platform offers comprehensive decision support, taking users from raw flow files to complete diagnostic reports. By focusing on the needs of hematology laboratories, Hema.to aims to enhance operational efficiency while ensuring high-quality results. Its tools are specifically designed to meet the unique requirements of clinical flow, empowering labs to provide better patient care through advanced technology.

Sanvivo

Seed Round in 2023
Sanvivo operates a comprehensive pharmacy management platform that facilitates the digital transformation of pharmacies. The company provides a multifaceted website where users can acquire prescription medications, receive pharmacy guidance, and reserve medical services from local pharmacies. Its platform includes various tools such as ordering applications, QR code solutions, and order management systems, along with customer communication and pharmacy consultation services. By integrating these features, Sanvivo aims to enhance the customer experience and streamline pharmacy operations, enabling pharmacies to connect with their clients more effectively.

Medicilio - Cantieri Digitali Medtech

Seed Round in 2023
At Cantieri Digitali Medtech, we launch innovative ventures in medical technology. With our experience in home medicine, software development, operations and seamless user experience, our aim is to offer high-quality, reliable and stress-free diagnostics and therapeutic services from the comfort of our patients’ own homes.

Apheris

Seed Round in 2022
Apheris specializes in network security for deep learning and privacy, providing a platform that enables secure data sharing and collaborative analysis of distributed datasets. By utilizing artificial intelligence, decentralized computing, federated learning, and cryptographic protocols, Apheris ensures that sensitive information remains protected in low or zero trust environments. This approach allows organizations to unlock the full potential of their data while adhering to stringent privacy and data protection regulations. The company’s solutions fundamentally change how organizations collaborate securely and extract value from their data, promoting a safer and more efficient analytical process.

Entyre

Series A in 2022
Entyre GmbH, founded in 2017 and based in Hamburg, Germany, operates an online platform that assists patients and caregivers in navigating bureaucratic processes within the healthcare system. The company utilizes proprietary data and algorithms to enhance decision-making for patients, doctors, and insurance companies by providing technical solutions that identify and rectify incorrect supplies. By evaluating outpatient care, Entyre enables users to better manage their healthcare needs and address the challenges posed by demographic changes. The company also offers contact information, including email, telephone numbers, and physical addresses, on its website to facilitate inquiries.

PeakData

Series A in 2022
PeakData is a software platform that leverages artificial intelligence to help pharmaceutical companies and healthcare professionals identify and analyze key opinion leaders within specific therapeutic areas. By utilizing advanced big data analysis and web mining techniques, the platform provides actionable insights that enhance targeting and segmentation strategies. It focuses on improving the understanding of physicians and their influence, while offering tools for expert mapping, profiling, and impact tracking. Through its innovative approach, PeakData aims to streamline data interpretation and empower stakeholders in the healthcare industry to make informed decisions.

Avi Medical

Series B in 2022
Avi Medical GmbH is a digital healthcare company based in Munich, Germany, founded in 2020. It specializes in telemedicine services, offering a platform that allows patients to book appointments, manage their health data, and communicate with healthcare practitioners through chat and video calls. By leveraging data-driven medicine, Avi Medical aims to enhance the collaboration between doctors and patients, providing a modern and efficient healthcare experience. The application facilitates access to medical consultations, enabling patients to receive care tailored to their needs across various locations.

Infermedica

Series B in 2022
Infermedica is a digital health company focused on improving the accuracy of medical diagnoses and optimizing the use of healthcare services. It provides AI-powered preliminary diagnosis and triage solutions to insurance companies, hospitals, and health systems, addressing issues related to misdiagnosis and inappropriate service utilization. The company's platform assists users by analyzing symptoms and facilitating communication with clinical staff for further diagnostics. Infermedica's tools have been utilized by over 6 million users globally, and it collaborates with more than 50 organizations, including notable partners in the healthcare sector. The company emphasizes the reliability of its recommendations by having a team of physicians review the medical database, ensuring that the information provided is accurate and safe. With over 100 employees and products available in 17 languages, Infermedica aims to enhance healthcare accessibility and reduce costs. Recent funding of $10.25 million will support its expansion in the United States and Europe and further technological development.

Ceregate

Series A in 2022
CereGate GmbH is a brain-machine interface company based in Hamburg, Germany, with an additional office in San Diego, California. Founded in 2019, the company specializes in developing a computer-brain interface (CBI) technology designed to enhance medical treatments by facilitating the direct transmission of information to neural circuits through existing neuromodulation implants. This innovative platform aims to improve the programming of neuromodulation systems, offering novel therapeutic options for patients with neurological disorders or sensory deficits. By enabling new forms of communication and sensory substitution, CereGate's technology provides patients with opportunities to adapt and improve their conditions, fostering greater independence and quality of life.

FORMEL Skin

Series A in 2021
FORMEL Skin is a healthtech start-up based in Berlin, Germany, founded in 2020. The company aims to transform dermatology by providing personalized, high-quality medical treatments through an online platform. FORMEL Skin offers a range of medical and science-based solutions designed to address various dermatological conditions. Its approach involves thorough consultations with dermatologists, ensuring that products are tailored to individual skin types and needs. This personalized treatment plan enables patients with skin issues to receive effective care that is specifically suited to their circumstances.

Apriwell

Seed Round in 2021
Apriwell specializes in providing natural health solutions aimed at addressing chronic conditions, particularly focusing on digestive health. The company offers a range of high-quality digestive supplements designed to enhance gut health through scientifically-supported formulations. Apriwell emphasizes a holistic approach, combining these products with a free health course that includes effective methods and exercises to support overall well-being. By prioritizing a human-centered experience, Apriwell aims to deliver comprehensive care to modern consumers seeking effective solutions for digestive issues such as constipation.

Sanome

Pre Seed Round in 2021
Sanome is focused on addressing the growing demand for healthcare services by enhancing early detection and prevention strategies. The company has developed a predictive analytics tool that aids clinicians in identifying patient health changes earlier, thereby improving decision-making in clinical settings. By integrating healthcare data with advanced artificial intelligence and biophysical biomarkers, including at-home composite tests, Sanome's platform provides actionable clinical insights. This approach enables healthcare providers to detect potential health issues before they escalate, ultimately leading to better patient outcomes and increased operational efficiency. The company's long-term vision includes creating a human digital twin that continuously monitors individual health, informing clinicians about significant changes through its Clinical Co-pilot.

Entyre

Pre Seed Round in 2021
Entyre GmbH, founded in 2017 and based in Hamburg, Germany, operates an online platform that assists patients and caregivers in navigating bureaucratic processes within the healthcare system. The company utilizes proprietary data and algorithms to enhance decision-making for patients, doctors, and insurance companies by providing technical solutions that identify and rectify incorrect supplies. By evaluating outpatient care, Entyre enables users to better manage their healthcare needs and address the challenges posed by demographic changes. The company also offers contact information, including email, telephone numbers, and physical addresses, on its website to facilitate inquiries.

Avi Medical

Series A in 2021
Avi Medical GmbH is a digital healthcare company based in Munich, Germany, founded in 2020. It specializes in telemedicine services, offering a platform that allows patients to book appointments, manage their health data, and communicate with healthcare practitioners through chat and video calls. By leveraging data-driven medicine, Avi Medical aims to enhance the collaboration between doctors and patients, providing a modern and efficient healthcare experience. The application facilitates access to medical consultations, enabling patients to receive care tailored to their needs across various locations.

LivNao

Seed Round in 2021
LivNao Technologies is a Vancouver-based company that utilizes deep learning technology to monitor and detect changes in mental health, aiming to enhance overall performance and productivity. By passively collecting data, LivNao's model identifies deviations in mental health before they impact an individual's performance. Upon detecting a change, the platform provides timely interventions tailored to the individual’s health plan. The company's approach redefines mental health management by enabling organizations, insurers, and healthcare systems to make informed, data-driven decisions in collaboration with individuals. LivNao is committed to promoting a healthier and more productive society while ensuring compliance with HIPAA regulations.

Actio

Seed Round in 2021
Actio, founded in 2019 in Berlin, Germany, offers a platform that connects users with professionals across various fields, including career, relationships, finance, cuisine, nutrition, sports, yoga, styling, and legal advice. The service allows individuals to book private meetings for tailored advice from experts. Additionally, Actio has developed a fitness coaching application that provides access to live workout sessions led by professional coaches, promoting fitness and mental well-being. This approach enables users to manage stress and reduce anxiety, fostering a healthier lifestyle.

Avi Medical

Seed Round in 2021
Avi Medical GmbH is a digital healthcare company based in Munich, Germany, founded in 2020. It specializes in telemedicine services, offering a platform that allows patients to book appointments, manage their health data, and communicate with healthcare practitioners through chat and video calls. By leveraging data-driven medicine, Avi Medical aims to enhance the collaboration between doctors and patients, providing a modern and efficient healthcare experience. The application facilitates access to medical consultations, enabling patients to receive care tailored to their needs across various locations.

Moray Medical

Seed Round in 2021
Moray Medical specializes in developing advanced robotic delivery systems for structural heart therapies, particularly focusing on edge-to-edge valve leaflet repair for patients with leaky heart valves. The company aims to enhance the quality of life for individuals suffering from this condition by offering innovative solutions that enable cardiologists to perform mitral valve clip therapies more safely and cost-effectively. Moray Medical's technology features a compact, reusable fluid-drive system that allows precise movement of flexible delivery catheters, facilitated by a digital interface akin to operating a computer cursor. This approach streamlines the treatment process, making life-saving heart valve therapies more accessible to a greater number of patients.

Ceregate

Series A in 2020
CereGate GmbH is a brain-machine interface company based in Hamburg, Germany, with an additional office in San Diego, California. Founded in 2019, the company specializes in developing a computer-brain interface (CBI) technology designed to enhance medical treatments by facilitating the direct transmission of information to neural circuits through existing neuromodulation implants. This innovative platform aims to improve the programming of neuromodulation systems, offering novel therapeutic options for patients with neurological disorders or sensory deficits. By enabling new forms of communication and sensory substitution, CereGate's technology provides patients with opportunities to adapt and improve their conditions, fostering greater independence and quality of life.

Infermedica

Series A in 2020
Infermedica is a digital health company focused on improving the accuracy of medical diagnoses and optimizing the use of healthcare services. It provides AI-powered preliminary diagnosis and triage solutions to insurance companies, hospitals, and health systems, addressing issues related to misdiagnosis and inappropriate service utilization. The company's platform assists users by analyzing symptoms and facilitating communication with clinical staff for further diagnostics. Infermedica's tools have been utilized by over 6 million users globally, and it collaborates with more than 50 organizations, including notable partners in the healthcare sector. The company emphasizes the reliability of its recommendations by having a team of physicians review the medical database, ensuring that the information provided is accurate and safe. With over 100 employees and products available in 17 languages, Infermedica aims to enhance healthcare accessibility and reduce costs. Recent funding of $10.25 million will support its expansion in the United States and Europe and further technological development.

Siilo

Series A in 2020
Siilo is a secure medical messaging application aimed at enhancing patient care by facilitating collaboration among healthcare professionals. Established in 2016 and headquartered in Amsterdam, the app allows physicians, nurses, and other staff to communicate effectively, thereby improving clinical collaboration, increasing productivity, and ultimately enhancing patient outcomes. Siilo features a secure and compliant messaging system that includes video calling capabilities and a web app. The platform ensures that personal and professional data remain separate on users' devices, storing patient information and discussions in an encrypted vault. This enables healthcare professionals to manage workflows, collaborate securely on patient treatments, and discuss challenging cases with their peers.

Actio

Seed Round in 2020
Actio, founded in 2019 in Berlin, Germany, offers a platform that connects users with professionals across various fields, including career, relationships, finance, cuisine, nutrition, sports, yoga, styling, and legal advice. The service allows individuals to book private meetings for tailored advice from experts. Additionally, Actio has developed a fitness coaching application that provides access to live workout sessions led by professional coaches, promoting fitness and mental well-being. This approach enables users to manage stress and reduce anxiety, fostering a healthier lifestyle.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.